106 related articles for article (PubMed ID: 1902259)
1. Isolation, physicochemical characterization and preclinical efficacy evaluation of soluble scleroglucan.
Pretus HA; Ensley HE; McNamee RB; Jones EL; Browder IW; Williams DL
J Pharmacol Exp Ther; 1991 Apr; 257(1):500-10. PubMed ID: 1902259
[TBL] [Abstract][Full Text] [Related]
2. Development, physicochemical characterization and preclinical efficacy evaluation of a water soluble glucan sulfate derived from Saccharomyces cerevisiae.
Williams DL; Pretus HA; McNamee RB; Jones EL; Ensley HE; Browder IW; Di Luzio NR
Immunopharmacology; 1991; 22(3):139-55. PubMed ID: 1774155
[TBL] [Abstract][Full Text] [Related]
3. Beta-glucan, a "specific" biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptor type 3 (CD11b/CD18).
Yan J; Vetvicka V; Xia Y; Coxon A; Carroll MC; Mayadas TN; Ross GD
J Immunol; 1999 Sep; 163(6):3045-52. PubMed ID: 10477568
[TBL] [Abstract][Full Text] [Related]
4. Soluble glucan and lymphokine-activated killer (LAK) cells in the therapy of experimental hepatic metastases.
Sherwood ER; Williams DL; McNamee RB; Jones EL; Browder IW; Di Luzio NR
J Biol Response Mod; 1988 Apr; 7(2):185-98. PubMed ID: 3283299
[TBL] [Abstract][Full Text] [Related]
5. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
6. Toxicology and carcinogenesis studies of p-nitrotoluene (CAS no. 99-99-0) in F344/N rats and B6C3F(1) mice (feed studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2002 May; (498):1-277. PubMed ID: 12118261
[TBL] [Abstract][Full Text] [Related]
7. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
[TBL] [Abstract][Full Text] [Related]
8. NTP Toxicology and Carcinogenesis Studies of Pyridine (CAS No. 110-86-1) in F344/N Rats, Wistar Rats, and B6C3F1 Mice (Drinking Water Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2000 Mar; 470():1-330. PubMed ID: 12579203
[TBL] [Abstract][Full Text] [Related]
9. Development of a water-soluble, sulfated (1-->3)-beta-D-glucan biological response modifier derived from Saccharomyces cerevisiae.
Williams DL; Pretus HA; McNamee RB; Jones EL; Ensley HE; Browder IW
Carbohydr Res; 1992 Nov; 235():247-57. PubMed ID: 1473107
[TBL] [Abstract][Full Text] [Related]
10. Characterization and immunostimulatory activity of an (1-->6)-a-D-glucan from the root of Ipomoea batatas.
Zhao G; Kan J; Li Z; Chen Z
Int Immunopharmacol; 2005 Aug; 5(9):1436-45. PubMed ID: 15953570
[TBL] [Abstract][Full Text] [Related]
11. Multiple antigens related to the major envelope glycoprotein of murine leukemia virus expressed on B16 melanoma cells as targets of host immune response.
Stackpole CW; Demsey A
Invasion Metastasis; 1984; 4(1):28-46. PubMed ID: 6329988
[TBL] [Abstract][Full Text] [Related]
12. NTP Toxicology and Carcinogenesis Studies of Phenolphthalein (CAS No. 77-09-8) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Nov; 465():1-354. PubMed ID: 12579199
[TBL] [Abstract][Full Text] [Related]
13. Short chain regioselectively hydrolyzed scleroglucans induce maturation of porcine dendritic cells.
Bimczok D; Wrenger J; Schirrmann T; Rothkötter HJ; Wray V; Rau U
Appl Microbiol Biotechnol; 2009 Feb; 82(2):321-31. PubMed ID: 19107473
[TBL] [Abstract][Full Text] [Related]
14. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
15. Vaccination with B16 melanoma cells expressing a secreted form of interleukin-1beta induces tumor growth inhibition and an enhanced immunity against the wild-type B16 tumor.
Björkdahl O; Dohlsten M; Sjögren HO
Cancer Gene Ther; 2000 Oct; 7(10):1365-74. PubMed ID: 11059695
[TBL] [Abstract][Full Text] [Related]
16. Receptor binding and internalization of a water-soluble (1-->3)-beta-D-glucan biologic response modifier in two monocyte/macrophage cell lines.
Müller A; Rice PJ; Ensley HE; Coogan PS; Kalbfleish JH; Kelley JL; Love EJ; Portera CA; Ha T; Browder IW; Williams DL
J Immunol; 1996 May; 156(9):3418-25. PubMed ID: 8617968
[TBL] [Abstract][Full Text] [Related]
17. A sequential multi-assay protocol for the preclinical assessment of natural product complex carbohydrate immunomodulators.
Williams DL; Pretus HA; McNamee RB; Jones EL
Dev Biol Stand; 1992; 77():129-36. PubMed ID: 1426653
[TBL] [Abstract][Full Text] [Related]
18. Orally administered beta-1,6-D-polyglucose extracted from Agaricus blazei results in tumor regression in tumor-bearing mice.
Oshiman K; Fujimiya Y; Ebina T; Suzuki I; Noji M
Planta Med; 2002 Jul; 68(7):610-4. PubMed ID: 12142994
[TBL] [Abstract][Full Text] [Related]
19. Orally administered beta-glucans enhance anti-tumor effects of monoclonal antibodies.
Cheung NK; Modak S; Vickers A; Knuckles B
Cancer Immunol Immunother; 2002 Nov; 51(10):557-64. PubMed ID: 12384807
[TBL] [Abstract][Full Text] [Related]
20. Inhibiting early activation of tissue nuclear factor-kappa B and nuclear factor interleukin 6 with (1-->3)-beta-D-glucan increases long-term survival in polymicrobial sepsis.
Williams DL; Ha T; Li C; Kalbfleisch JH; Laffan JJ; Ferguson DA
Surgery; 1999 Jul; 126(1):54-65. PubMed ID: 10418593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
